Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 3:54 PM ET

Health Care Technology

Company Overview of Molecular Health GmbH

Company Overview

Molecular Health GmbH develops a computational system that transforms molecular data into clinically actionable information to provide various cancer treatment options for cancer patients. The company offers TreatmentMAP, a treatment decision support solution that guides physicians and patients in the use of genetic, clinical, molecular, and efficacy data. Its solutions include TreatmentMAP-targeted panel, a test that includes various genetic variants that develop a treatment plan for newly diagnosed solid tumor cancer; and TreatmentMAP-whole exome, which analyzes various genes to identify generic variation against a patient’s normal gene set in the areas of difficult to treat cancers. The c...

Kurfuersten-Anlage 21

Heidelberg,  69115

Germany

Founded in 2004

Phone:

49 6221 43851 0

Fax:

49 6221 43851 100

Key Executives for Molecular Health GmbH

Chief Executive Officer and President
Founder and Chairman
Age: 53
Co-Founder
Chief Operating Officer
Chief Innovation Officer
Compensation as of Fiscal Year 2015.

Molecular Health GmbH Key Developments

Molecular Health Opens Berlin Office to Support Growing Demand for Digital Health Solutions

Molecular Health announced that the company has opened an office in Berlin, Germany to accelerate the growing European demand for its suite of digital health solutions. Located on Friedrichstrasse in downtown Berlin close to the government district, the new office reflects Molecular Health's continued corporate growth and will enable the company to further strengthen its relationships with policy makers and patient advocacy groups in Germany.

Molecular Health GmbH Presents at Hume Brophy 7th Annual Healthcare Conference, Oct-15-2015

Molecular Health GmbH Presents at Hume Brophy 7th Annual Healthcare Conference, Oct-15-2015 . Venue: CityPoint, 1 Ropemaker Street, London EC2Y 9SS, United Kingdom.

Molecular Health Licenses SafetyMAP(TM) to U.S. Food and Drug Administration (FDA)

Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAPTM software - formally known as Molecular Analysis of Side Effect information (MASETM), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates. The license supplies the FDA with access to SafetyMAP for 10 concurrent users for a period of one year and can be extended for two additional years at the discretion of the FDA. The FDA described in its RFQ the important capability that Molecular Health's technology provides: Drug safety prediction and the evaluation of post-marketing signals depend on the ability to find scientific data that can confirm relationships among drugs, drug targets, toxicity mechanism, patient susceptibility and clinical response. This requires the ability to interrogate a wide variety of data sources, including the FAERS database, MEDLINE, gene and protein databases, FDA drug product labels, patents and other document repositories to uncover hidden relationships between scientific findings and adverse events. The creation of molecular target adverse event profiles is advancing safety science. This capability is mission critical for assessing the importance of possible safety issues pre- and post-approval and for supporting regulatory science mission at FDA.

Similar Private Companies By Industry

Company Name Region
Pharmatching GmbH Europe
PHARMATECHNIK GmbH & Co. KG Europe
Nexus/Holl GmbH Europe
FREY ADV GmbH Europe
Werum IT Solutions GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 16, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Molecular Health GmbH, please visit www.molecularhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.